A Look Ahead: Biomarin Pharmaceutical's Earnings Forecast

Biomarin Pharmaceutical (NASDAQ:BMRN) is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.52.

The announcement from Biomarin Pharmaceutical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.61, leading to a 7.95% increase in the share price on the subsequent day.

Here's a look at Biomarin Pharmaceutical's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.35

0.34

0.23

0.22

EPS Actual

0.96

0.71

0.49

0.46

Price Change %

8.0%

-10.0%

1.0%

-5.0%

Market Performance of Biomarin Pharmaceutical's Stock

Shares of Biomarin Pharmaceutical were trading at $69.73 as of October 25. Over the last 52-week period, shares are down 14.11%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Insights Shared by Analysts on Biomarin Pharmaceutical

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Biomarin Pharmaceutical.

A total of 27 analyst ratings have been received for Biomarin Pharmaceutical, with the consensus rating being Outperform. ...